Shopping Cart

Your shopping cart is currently empty

Lanreotide acetate

Name: Lanreotide acetate
Brand: TargetMol
SKU: T8359
Price: 37 USD
Availability: InStock
Rating: 5 (10 reviews)

😃Good

Catalog No. T8359Cas No. 2378114-72-6

Alias Lanreotide acetate (108736-35-2 free base), BIM 23014 acetate, BIM 23014 (acetate)

Lanreotide acetate (BIM 23014 acetate) is a somatostatin analogue with antineoplastic activity, used for carcinoid syndrome

Lanreotide acetate

😃Good

Catalog No. T8359Alias Lanreotide acetate (108736-35-2 free base), BIM 23014 acetate, BIM 23014 (acetate)Cas No. 2378114-72-6

Lanreotide acetate (BIM 23014 acetate) is a somatostatin analogue with antineoplastic activity, used for carcinoid syndrome

Pack Size	Price	USA Warehouse	Global Warehouse
2 mg	$37	In Stock	In Stock
5 mg	$59	In Stock	In Stock
10 mg	$97	In Stock	In Stock
25 mg	$176	In Stock	In Stock
50 mg	$262	-	In Stock
100 mg	$389	-	In Stock
1 mL x 10 mM (in DMSO)	$133	In Stock	In Stock

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Batch Information

Select Batch

Purity:>99.99%

Appearance:Solid

Color:White

Resource Download

COA

Product Introduction

Bioactivity

Description	Lanreotide acetate (BIM 23014 acetate) is a somatostatin analogue with antineoplastic activity, used for carcinoid syndrome
In vivo	In a mouse GH3 tumor xenograft model, lanreotide 10 mg/kg moderately inhibited the growth of GH3 tumors, with a 4x tumor growth delay (TGD) time that ranged from 4.5 to 8.3 days. Fractionated local tumor radiation alone significantly inhibited tumor growth and produced a TGD of 35.1+/-5.7 days for 250 cGy fractions[1].
Animal Research	Animal Model:Male nude mice, 8 weeks old and 20–25?g in body weight (GH3 tumor-bearing nude mice).Dosage: 2.5, 5, 10?mg/kg. Administration:Subcutaneous; daily for 5 days[1]
Synonyms	Lanreotide acetate (108736-35-2 free base), BIM 23014 acetate, BIM 23014 (acetate)

Chemical Properties

Molecular Weight	1156.39
Formula	C₅₆H₇₃N₁₁O₁₂S₂
Cas No.	2378114-72-6
Smiles	CC(O)=O.[H][C@@]1(CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@]([H])(CSSC[C@H](NC(=O)[C@@H](NC1=O)C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)NC(=O)[C@H](N)Cc1ccc2ccccc2c1
Relative Density.	no data available
Sequence	H-DL-2Nal-DL-Cys(1)-DL-Tyr-DL-Trp-DL-Lys-DL-Val-DL-Cys(1)-DL-xiThr-NH2
Sequence Short	XCYWKVCX

Storage & Solubility Information

Storage

keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 125 mg/mL (108.1 mM), Sonication is recommended.

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (1.73 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	0.8648 mL	4.3238 mL	8.6476 mL	43.2380 mL
5 mM	0.1730 mL	0.8648 mL	1.7295 mL	8.6476 mL
10 mM	0.0865 mL	0.4324 mL	0.8648 mL	4.3238 mL
20 mM	0.0432 mL	0.2162 mL	0.4324 mL	2.1619 mL
50 mM	0.0173 mL	0.0865 mL	0.1730 mL	0.8648 mL
100 mM	0.0086 mL	0.0432 mL	0.0865 mL	0.4324 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc